Skip to content

Blogs

The Case Against These Two Hot COVID-19 Vaccine Stocks

The two biotechs that are the focus of today’s article have been hot this year, with shares of both having experienced triple-digit growth. The reason? Their respective COVID-19 vaccine development programs, which have moved at lightning-fast speed.

5 Biotech Penny Stocks To Watch Amid An “Unfounded” Time For The Space

“The fact that more than 9 months of this year have been focused on the space is unfounded. In fact, I don’t remember one industry in recent history that has so captivated the stock market as much as this,” says the author of today’s article of the biotech space – and biotech penny stocks in particular.

Unmet Needs And Niche Markets: These Pharma Stocks Have The Momentum

While the surge in interest in pharmaceutical stocks this year has been primarily driven by factors related to the COVID-19 pandemic, the author of today’s article advises that “companies working on pharmaceutical products for unmet needs or other niche markets such as animal health could be worth a closer look.”

A Friday Flurry Of Biotech IPOs

A look at the four biotech companies going public Friday – which include two firms developing small molecule therapies to treat cancer.